Clinical Trial Update: A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis [Phase 2]

View source ↗

Summary

Phase 2 trial of BGS649 in women with refractory endometriosis was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis
• Pelvic Pain

Drugs mentioned

• BGS649

Snippet

Sponsor: Mereo BioPharma | Conditions: Pelvic Pain Associated With Refractory Endometriosis | Phase 2 | Status: TERMINATED | Results posted: 2020-10-30